However, we found both anti-apoA-I and anti-apoB immunoreactivity in ccRCC tissue and patient-derived cell culture, possibly due to uptake from the serum-containing cell culture media. The gene discussed is APOA1; the disease is nonpapillary renal cell carcinoma.